NOXAFIL® (pozakonazol) – Refrakter kezelés


1. Torrisi JM, Schwartz LH, Gollub MJ, et al. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology. 2011;258(1):41–56. doi:10.1148/radiol.10092129..

2. Kubo K, Azuma A, Kanazawa M, et al. Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Respir Investig. 2013;51(4):260–277. doi:10.1016/j.resinv.2013.09.001.

3. Cytostar alkalmazási előírás, 2016. február 22.

4. Cohen N, Dubnow S, Paskovaty A, Seo SK. Antifungal prophylaxis in high-risk oncology patients. Pharm Pract News. 2010:1–15.

5. Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21(3):389–401. doi:10.1016/j.bbmt.2014.12.001..

6. Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100(13):4358–4366. doi:10.1182/ blood-2002-05-1496.

7. Neofytos D, Lu K, Hatfield-Seung A, et al. Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy. Diagn Microbiol Infect Dis. 2013;75(2):144–149. doi:10.1016/j.diagmicrobio.2012.10.001.

8. NCCN clinical practice guidelines in oncology (NCCN Guidelines®): prevention and treatment of cancer-related infections: version 1.2017. National Comprehensive Cancer Network website. Accessed February 22, 2017.

9. Lewis RE, Cahyame-Zuniga L, Leventakos K, et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013;56(6):638–645. doi:10.1111/myc.12081.


Referenciák folytatása